BiVACOR, a clinical-stage medical device company, has announced the successful completion of the first phase of its FDA Early Feasibility Study (EFS) for the BiVACOR Total Artificial Heart (TAH). Between July and November 2024, five patients received the BiVACOR TAH…
Cellular remote patient monitoring (RPM) from Smart Meter is a crucial tool for ensuring continuous, high-quality care, particularly during the busy holiday season. As the Centers for Disease Control and Prevention (CDC) reports, around 23% of patients with chronic conditions—roughly…
LivaNova PLC (Nasdaq: LIVN), a leading medical technology company, has announced the publication of two pivotal articles in Brain Stimulation journal detailing data from the unipolar cohort of its RECOVER clinical study. This research evaluates the safety and efficacy of…
Hologic, Inc. (Nasdaq: HOLX) announced today that it has signed an agreement with the Centers for Disease Control and Prevention (CDC) to develop analyte specific reagents (ASRs) — key components of laboratory-developed tests — to assist in detecting H5N1 bird…
Sensorion, a clinical-stage biotechnology company focused on hearing loss therapies, has announced promising safety data from its Phase 1/2 clinical trial, Audiogene, for SENS-501. This gene therapy targets congenital deafness caused by mutations in the OTOF (otoferlin) gene, which is…
CardioFocus, Inc., a medical device company focused on advancing ablation treatments for cardiac arrhythmias, has announced the successful treatment of the first group of patients using the investigational OptiShot™ Pulsed Field Ablation (PFA) System. This marks a significant milestone in…
Life Line Screening, the nation’s top provider of preventive screenings, has introduced its new Mid-Year Health Check Screening. This mid-cycle biometric screening is designed to help individuals track their health between their annual cardiovascular and stroke risk assessments. The Mid-Year…
Hyperfine, Inc. (Nasdaq: HYPR), a pioneering health technology company known for its AI-powered portable MRI brain imaging system, the Swoop® system, has announced further global expansion with new distribution agreements in Turkey, Israel, and Saudi Arabia. These agreements are part…
Tempus AI, Inc. (NASDAQ: TEM), a leader in AI-driven precision medicine and patient care, today revealed the impact of a recent decision by the Centers for Medicare and Medicaid Services (CMS) to approve reimbursement for cardiac dysfunction assessments using the…
MGA Homecare, a prominent provider of home and community-based physical and behavioral health services, has announced its acquisition of Ward Road Pharmacy (WRP), a Long-Term Care Pharmacy (LTCP) and Home Medical Supply (HMS) company located in Arvada, CO. This strategic…
KARL STORZ USA is proud to announce that its VITOM® eagle exoscope with ARTip CRUISE® motorized holding system has been awarded the Innovative Technology designation by Vizient, Inc., the leading healthcare performance improvement organization in the U.S. The VITOM eagle…
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company pioneering novel bioelectric medicine with its proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA™) technology, announced a new publication in the Journal of Thoracic and Cardiovascular Surgery. The preclinical study demonstrates the advantages of Pulse…